ZZZhaowei Zhu

Zhaowei Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhaowei Zhu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Xuepei Zhang

    Department of Urology, The First Affiliated Hospital of Zhengzhou University

    13 shared publications
  • Pin Zhao

    Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    6 shared publications
  • Jiange Wang

    Department of Urology Suizhou Central Hospital Suizhou Hubei P. R. China

    5 shared publications
  • Lijuan Guo

    Department of Disease Prevention and Control, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    4 shared publications
  • Liyuan Duan

    Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    3 shared publications
  • Shilong Xue

    Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China

    3 shared publications

Latest Publications

  • Open Access

    Spatiotemporal Trends and Structural Drivers of Prostate Cancer Burden in East Asia from 1990 to 2023: A Joinpoint Regression and Decomposition Analysis Based on the Global Burden of Disease Study 2023

    by Peng Li, Yafei Li, Hailiang Zou, Jiawei Xing, Junfeng Liang, Yue Gu, Zhaowei Zhu

    Background Prostate cancer burden is rising in East Asia amid rapid demographic transition. We assessed spatiotemporal trends and structural drivers from 1990 to 2023, separating the effects of population ageing, population growth, and age-specific epidemiological rates. Methods Using Global Burden of Disease Study 2023 estimates, we extracted prostate cancer data for mainland China, Taiwan of China, Japan, South Korea, North Korea, and Singapore; global and US estimates were included as descriptive comparators. Joinpoint regression assessed long-term trends in crude and age-standardised rates. Das Gupta decomposition quantified the contributions of population size, age structure, and age-specific epidemiological rates to changes in absolute burden. Findings Growth in crude rates consistently exceeded growth in age-standardised rates across the study locations. Age-standardised incidence increased substantially, particularly in South Korea (235·50%) and Taiwan of China (210·44%). Mainland China showed a 52·07% increase in age-standardised incidence alongside a 16·03% reduction in age-standardised mortality. Population ageing was a positive contributor to rising absolute burden across the study locations and exceeded the population-size contribution for incident cases in Japan, South Korea, and mainland China. Interpretation Population ageing is reshaping the absolute prostate cancer burden in East Asia. Health-care planning should use crude rates to anticipate service demand, and locally calibrated, risk-stratified early-detection policies should be evaluated in the context of each health system.

  • Open Access

    Association between urinary bisphenol A and overactive bladder: Evidence from the NHANES 2003–2016

    by Zhaowei Zhu, Yuan Liu, Liyuan Duan, Gaurab Pokhrel, Jinjin Feng, Xiang Han, Xuepei Zhang


  • Open Access

    Exploring the underlying mechanisms of Hedyotis diffusa and Scutellaria Barbata herb pair on the prognosis and treatment efficacy of bladder cancer patients: an integrated approach of network pharmacology and bioinformatics analysis

    by Yuan Liu, Liyuan Duan, Mengwei Zhu, Zhenzhen Zhou, Pin Zhao, Yonghao Zhan, Xuepei Zhang, Zhaowei Zhu

    The development and progression of bladder cancer are closely linked to its complex tumor microenvironment. Hedyotis diffusa and Scutellaria barbata (HD-SB

  • Open Access

    Association of cancer with overactive bladder and impact of overactive bladder on mortality among cancer survivors: NHANES 1999-2018

    by Bin Zhi, Pin Zhao, Liyuan Duan, Yuan Liu, Zhaowei Zhu, Xuepei Zhang

    Background: Cancer is one of the leading causes of death worldwide. There is little knowledge on the association between cancer and risk of overactive bladder (OAB). Additionally, the impact of OAB on mortality among cancer survivors remains unknown. We aimed to examine the association between cancer and risk of OAB and investigate OAB associations with mortality outcomes in cancer survivors. Methods: We analyzed data of the National Health and Nutrition Examination Survey from 1999 to 2018. Cancer status was identified through the NHANES questionnaire. OAB was diagnosed with a cumulative OAB Symptom Score ≥ 3. Multivariable logistic analysis was performed to examine the relationship between cancer and OAB. Cox regression analysis was carried out to investigate the relationship between OAB and mortality in subjects with cancer. Results: In total, this study included a cohort of 32,166 participants. Within the study population, the occurrence of cancer was observed in 9.606%, and OAB was prevalent in 20.167%. The findings from the logistic regression analyses indicated a heightened risk of OAB among individuals with cancer in comparison to those devoid of cancer. Results from subgroup analyses also revealed affirmative correlations between cancer and OAB. Furthermore, the diagnosis of cancer, irrespective of whether it was genitourinary, non-genitourinary, pelvic, or non-pelvic in nature, was found to be correlated with an increased risk of OAB. Within the cohort comprising 3,090 participants diagnosed with cancer, a total of 850 all-cause deaths were recorded during a median follow-up duration of 76 months. After accounting for multiple covariates, OAB was linked to an elevated risk of all-cause and cancer-specific mortality. Moreover, the influence of OAB on mortality from all causes was observed across various cancer types, including both genitourinary and non-genitourinary, as well as pelvic and non-pelvic cancers. Conclusions: The investigation identified a noteworthy positive correlation between cancer and the likelihood of OAB. Moreover, OAB was significantly correlated with an elevated risk of mortality among individuals who had received a cancer diagnosis.

  • Open Access

    Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease

    by Pin Zhao, Zhenhao Li, Shilong Xue, Jinshan Cui, Yonghao Zhan, Zhaowei Zhu, Xuepei Zhang

    There is an urgent need to pinpoint novel targets for drug discovery in the context of chronic kidney disease (CKD), and the proteome represents a significant pool of potential therapeutic targets. To address this, we performed proteome-wide analyses using Mendelian randomization (MR) and colocalization techniques to uncover potential targets for CKD. We extracted summary-level data from the ARIC study, focusing on 7213 European American (EA) individuals and 4657 plasma proteins. To broaden our analysis, we incorporated genetic association data from Icelandic cohorts, thereby enhancing our investigation into the correlations with chronic kidney disease (CKD), creatinine-based estimated glomerular filtration rate (eGFRcrea), and estimated glomerular filtration rate (eGFR). We utilized genetic association data from the GWAS Catalog, including CKD (765,348, 625,219 European ancestry and 140,129 non-European ancestry), eGFRcrea (1,004,040, European ancestry), and eGFR (567,460, European ancestry). Employing MR analysis, we estimated the associations between proteins and CKD risk. Additionally, we conducted colocalization analysis to evaluate the existence of shared causal variants between the identified proteins and CKD. We detected notable correlations between levels predicted based on genetics of three circulating proteins and CKD, eGFRcrea, and eGFR. Notably, our colocalization analysis provided robust evidence supporting these associations. Specifically, genetically predicted levels of Transcription elongation factor A protein 2 (TCEA2) and Neuregulin-4 (NRG4) exhibited an inverse relationship with CKD risk, while Glucokinase regulatory protein (GCKR) showed an increased risk of CKD. Furthermore, our colocalization analysis also supported the associations of TCEA2, NRG4, and GCKR with the risk of eGFRcrea and eGFR.


  • Open Access

    Association of urinary bisphenol A with hyperlipidemia and all-cause mortality: NHANES 2003–2016

    by Lijuan Guo, Pin Zhao, Shilong Xue, Zhaowei Zhu

    Background: The connection between urinary bisphenol A (BPA) and hyperlipidemia is still unclear, and few studies have evaluated whether urinary BPA affects mortality among individuals with hyperlipidemia. Therefore, we aimed to investigate the link between urinary BPA and hyperlipidemia and assess the impact of urinary BPA on mortality risk in subjects with hyperlipidemia. Methods: We analyzed data of the National Health and Nutrition Examination Survey from 2003 to 2016. Multivariable logistic analysis was performed to examine the relationship between urinary BPA and hyperlipidemia. Cox regression analysis was carried out to investigate the relationship between urinary BPA and all-cause mortality in subjects with hyperlipidemia. Results: This study included 8,983 participants, of whom 6,317 (70.3%) were diagnosed with hyperlipidemia. The results showed that urinary BPA was higher in participants with hyperlipidemia group than those without hyperlipidemia (3.87 ± 0.32 vs. 2.98 ± 0.14, P = 0.01). Urinary BPA levels were analyzed in tertiles. Compared with tertile 1 of BPA (reference), the odds ratio (95% confidence interval) of hyperlipidemia related to tertile 3 of BPA was 1.28 (1.11–1.48). The hazard ratio for all-cause death associated with the highest versus lowest tertile of urinary BPA was 1.20 (95% confidence interval: 1.01–1.44; P = 0.04) among participants with hyperlipidemia. Conclusions: The study indicated a positive relationship between urinary BPA and the risk of hyperlipidemia. Urinary BPA was associated with a significantly higher risk of all-cause mortality in adults with hyperlipidemia.


  • Open Access

    Hematological markers and prostate cancer risk: A Mendelian randomization study

    by Pin Zhao, Zhaowei Zhu, Xuepei Xuepei Zhang

    BackgroundProspective study has indicated an association between hematological markers and the risk of prostate cancer. However, such associations are easily influenced by confounding or reverse causality. Therefore, we performed a two-sample Mendelian randomization (MR) analysis to assess the independent causal effects of hematological markers on the risk of prostate cancer.MethodsWe conducted Mendelian randomization (MR) analyses using publicly available full association studies (GWAS) data, which included 79,148 cases of prostate cancer and 61,106 controls. The analysis revealed that 378 single nucleotide polymorphisms (SNPs) were strongly correlated with mean corpuscular volume, 366 SNPs were tightly linked with mean corpuscular hemoglobin, and 102 SNPs were intricately connected with mean hemoglobin concentration. The primary estimate was obtained using the inverse-variance weighted method, while MR Pleiotropy RESidual Sum and Outlier, MR-Egger, and weighted median methods were utilized to identify heterogeneity and pleiotropy.ResultsIn the meta-analysis of our results, elevated mean corpuscular volume was found to be associated with a decreased risk of prostate cancer (odds ratio [OR] 0.94, 95% confidence interval [CI] 0.90–0.98; P = 0.004). Mean corpuscular hemoglobin (odds ratio [OR] 0.95, 95% confidence interval [CI] 0.91–0.99; P = 0.019) and mean corpuscular hemoglobin concentration (odds ratio [OR] 0.89, 95% confidence interval [CI] 0.81–0.98; P = 0.023) are both associated with a reduced risk of prostate cancer.ConclusionsThis Mendelian randomization study provides evidence supporting the notion that elevated levels of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) may lower the risk of prostate cancer.


  • Open Access

    Impedance of whole body plays a crucial role in the pathway from rheumatoid arthritis to prostate cancer: a Mendelian randomization study

    by Pin Zhao, Yonghao Zhan, Shilong Xue, Zhaowei Zhu, Xuepei Zhang

    Background: An earlier observational study has indicated a potential link between rheumatoid arthritis and a higher chance of developing prostate cancer, but the exact causal direction and the role of impedance of whole body in this association remain unclear. To address this gap in knowledge, we conducted two-sample univariable and multivariable MR analyses to assess the total and direct effects of rheumatoid arthritis and whole-body impedance on prostate cancer risk. Methods: The primary estimate was derived using the inverse-variance weighted method, and additional methods such as MR Pleiotropy. We conducted two-sample univariable and multivariable MR analyses to assess the total and direct effects of rheumatoid arthritis and whole-body impedance on prostate cancer risk. Two-sample Mendelian randomization (MR) was utilized to examine the independent causal effects of rheumatoid arthritis on whole-body impedance. The primary estimate was derived using the inverse-variance weighted method, and additional methods such as MR Pleiotropy RESidual Sum and Outlier, MR-Egger, and weighted median were employed to detect any heterogeneity or pleiotropy. In our meta-analysis, we found that both rheumatoid arthritis and impedance of whole body were associated with an increased risk of prostate cancer (rheumatoid arthritis: OR = 1.03, 95% CI = 1.01−1.05, p=0.003; impedance of whole body: OR =1.11, 95% CI =1.02 -1.20, P =0.015). Furthermore, the MR analysis provided evidence to support the notion that rheumatoid arthritis can increase the risk of impedance of whole body (OR= 1.01.95% confidence interval [CI] 1.004-1.013; p = 0.0002). There was little evidence that rheumatoid arthritis influenced prostate cancer once impedance of whole body was controlled for, whereas impedance of whole body could significantly affect prostate cancer independently of rheumatoid arthritis (IVW: p=0.018). Results: Mendelian randomization study offers evidence to support the idea that impedance of whole body seems to have a significant impact on the link between rheumatoid arthritis and prostate cancer.

  • Open Access

    CircOMA1 promotes tumour growth and metastasis of bladder cancer by modulating IGF‐IR/MAPK/EMT pathway

    by Lianghao Zhang, Yonghao Zhan, Longqing Li, Haotian Deng, Jiange Wang, Zhaowei Zhu, Xuepei Zhang